Neo-Bioscore in Guiding Post-surgical Therapy in Patients With Triple-negative Breast Cancer Who Received Neoadjuvant Chemotherapy

Aim: Patients with triple-negative breast cancer (TNBC) who have not achieved pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) were considered for adjuvant capecitabine. This study was to explore the utility of the Neo-Bioscore in guiding post-surgical therapy in TNBC. Patie...

Full description

Saved in:
Bibliographic Details
Published in:In Vivo
Main Authors: HASEGAWA, YORIKO, MATSUBARA, NOBUAKI, KOGAWA, TAKAHIRO, NAITO, YOICHI, HARANO, KENICHI, HOSONO, AKO, ONISHI, TATSUYA, HOJO, TAKASHI, SHIMOKAWA, MOTOTSUGU, MUKOHARA, TORU
Format: Artigo
Language:Inglês
Published: International Institute of Anticancer Research 2021
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045094/
https://ncbi.nlm.nih.gov/pubmed/33622900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12348
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items